Related by context. All words. (Click for frequent words.) 71 elevated triglycerides 69 mitochondrial toxicity 69 insulin resistance syndrome 68 myopathy rhabdomyolysis 68 plasma lipid 68 T2DM 68 hypercholesterolaemia 68 elevated CRP 68 elevated triglyceride levels 68 extrapyramidal symptoms 67 dyslipidaemia 67 HDL2 67 elevated LDL cholesterol 67 nonalcoholic steatohepatitis NASH 67 colorectal adenoma 67 elevated ALT 67 mixed hyperlipidemia 67 abnormal lipid 67 statin medications 67 abdominal adiposity 67 2 diabetes T2D 67 NAFLD 67 hepatic cirrhosis 67 onset diabetes mellitus 67 genetic variants associated 67 haloperidol Haldol 67 HMG CoA reductase inhibitors 66 macrovascular events 66 lipid lowering therapies 66 primary hypercholesterolemia 66 subclinical atherosclerosis 66 metabolic abnormalities 66 basal cell nevus syndrome 66 gestational diabetes mellitus 66 β blockers 66 thromboembolic disease 66 dysglycemia 66 inflammatory biomarkers 66 potentially modifiable 66 hyperkalemia 66 systolic hypertension 66 contrast induced nephropathy 66 antihypertensive therapy 66 hereditary predisposition 66 Thiazolidinediones 66 subclinical hyperthyroidism 66 intravenous bisphosphonates 66 antidiabetic drugs 66 dyslipidemias 66 transferrin saturation 66 acarbose 66 MGUS 66 tHcy 66 fibrate drugs 66 hyperglycaemia 65 SGPT 65 albuminuria 65 hypertension diabetes mellitus 65 HBeAg negative 65 macroalbuminuria 65 lipid disorders 65 endometrial hyperplasia 65 prostate cancer CaP 65 antihypertensive medications 65 ABCB1 65 macrovascular disease 65 Nonalcoholic fatty liver 65 unmeasured confounders 65 pulmonary hypertension PH 65 lipid parameters 65 polyp recurrence 65 myeloproliferative neoplasms 65 ATACAND 65 epithelial tumors 65 neuropsychiatric symptoms 65 atherogenic dyslipidemia 65 genetic polymorphisms 65 hypercalciuria 65 hepatotoxicity 65 abnormal glucose tolerance 65 cardiovascular morbidity 65 hyperinsulinemia 65 serum leptin 65 type2 diabetes 65 elevated fasting glucose 65 K ras mutations 65 myeloproliferative diseases 65 renal toxicity 65 cardiac troponin T 65 glitazones 65 transaminase elevations 65 susceptibility loci 65 serum GGT 65 behavioral disinhibition 65 lipid lowering agents 64 Torsades de Pointes 64 obesity insulin resistance 64 metabolic disturbances 64 cystatin C 64 NNRTI resistance 64 ziprasidone Geodon 64 cardiometabolic risk 64 thiazide 64 coinfected patients 64 nonmelanoma skin cancers 64 intact parathyroid hormone 64 glycated hemoglobin levels 64 CTAP# Capsules 64 antidiabetic medication 64 prostate cancer PCa 64 leukotriene receptor antagonists 64 hematopoietic cancers 64 recurrent venous thromboembolism 64 Atypical antipsychotics 64 diabetes mellitus DM 64 metabolic parameters 64 Epidemiologic studies 64 Genetic variants 64 Cognitive impairment 64 narcolepsy cataplexy 64 serum triglycerides 64 hypovitaminosis D 64 diabetes dyslipidemia 64 sulphonylureas 64 treatment emergent AEs 64 G6PD deficiency 64 prostate carcinogenesis 64 erlotinib Tarceva ® 64 myeloproliferative disorders 64 CYT# potent vascular disrupting 64 atherosclerotic vascular disease 64 advanced adenomas 64 hypercholesterolemia 64 primary aldosteronism 64 fluvastatin 64 fasting glucose levels 64 subclinical hypothyroidism 64 chlorthalidone 64 diabetic kidney 64 gallstone disease 64 acamprosate 64 triglycerides TG 64 metformin sulfonylurea 64 Non Alcoholic Fatty 64 thrombophilia 64 somatostatin analogs 64 nonalcoholic steatohepatitis 64 Hypoglycaemia 64 glycosylated hemoglobin HbA1c 64 diabetes mellitus T2DM 64 juvenile idiopathic arthritis JIA 64 grade cervical intraepithelial 63 paricalcitol 63 antihypertensive drugs 63 disease NAFLD 63 impaired glucose metabolism 63 NATRECOR ® 63 serum phosphate 63 carotid atherosclerosis 63 immunosuppressive therapies 63 diabetes hyperlipidemia 63 elevated LDL 63 monoamine oxidase inhibitors 63 Hashimoto thyroiditis 63 CVD mortality 63 prolonged QT interval 63 antiplatelet medications 63 pyridostigmine 63 Venous thromboembolism 63 chlamydial infection 63 cervical intraepithelial neoplasia 63 MTHFR 63 Non Alcoholic Steatohepatitis 63 endometrial cancers 63 diabetes mellitus 63 hypertensives 63 renal dysfunction 63 colorectal neoplasia 63 cranial irradiation 63 secondary hyperparathyroidism 63 glucose intolerance 63 serum calcium 63 DFMO 63 PTEN mutations 63 Fibrates 63 concomitant medications 63 torsade de pointes 63 T1DM 63 haematologic 63 lipohypertrophy 63 Lp PLA2 63 hemorrhagic complications 63 hyperhomocysteinemia 63 Fatty Liver Disease 63 anticonvulsant medications 63 airway hyperresponsiveness 63 androgen deficiency 63 rosuvastatin Crestor 63 apolipoproteins 63 breast endometrial 63 receiving VELCADE 63 AST ALT 63 postoperative delirium 63 risperidone Risperdal 63 etiologic 63 thromboembolism 63 NOMID 63 aminotransferases 63 hypoglycemic events 63 antiplatelet drugs 63 leiomyomas 63 HbA 1c 63 Prehypertension 63 imatinib resistance 63 thromboembolic complications 63 microalbuminuria 63 abnormal lipids 63 isolated systolic hypertension 63 idiopathic PAH 63 atypical neuroleptics 63 chronic pancreatitis 63 apolipoprotein B 63 metformin sulphonylurea 63 gene polymorphisms 63 Genetic predisposition 63 Darapladib 63 co morbidities 63 benazepril 63 1 diabetes T1D 63 proliferative diabetic retinopathy 63 node metastases 63 newer atypical antipsychotics 63 pharmacokinetic interactions 63 Sleep disordered breathing 63 UGT#A# * 63 serum cholesterol 63 T2D 63 intensive statin therapy 63 hypercalcemia 63 Zollinger Ellison Syndrome 63 serum lipid levels 62 TEAEs 62 endometrial carcinoma 62 plasma lipoprotein 62 antiemetics 62 esophageal adenocarcinoma 62 alanine aminotransferase ALT 62 myeloperoxidase 62 hypoglycemic episodes 62 lipid levels 62 thiazides 62 lowering triglyceride levels 62 lysosomal storage diseases 62 familial hypercholesterolemia 62 Bisphosphonate 62 anticholinergic medications 62 hsCRP 62 angiotensin receptor blockers ARBs 62 elevated serum creatinine 62 mycophenolate mofetil 62 HIV HCV coinfected 62 cerebral microbleeds 62 paroxetine Paxil 62 induce orthostatic hypotension 62 Erythropoietic therapies may 62 intima media thickness 62 dopamine receptor gene 62 carotid IMT 62 chronic prostatitis 62 MDRD equation 62 vasomotor symptoms 62 Glucocorticoids 62 myelofibrosis polycythemia vera 62 candidemia 62 cardiovascular mortality 62 adrenal suppression 62 Leukemias 62 abnormal lipid levels 62 steatosis 62 hemodilution 62 receptor blockers 62 loop diuretic 62 ADPKD 62 prognostic significance 62 hs CRP 62 lipoprotein levels 62 carotid stenosis 62 Insulin detemir 62 hormone receptor negative 62 clozapine Clozaril 62 baseline HbA1c 62 venlafaxine Effexor 62 hyperuricemia 62 esophageal squamous cell carcinoma 62 TCF#L# gene 62 SE alleles 62 overt nephropathy 62 pentoxifylline 62 CrCl 62 TPMT 62 conventional antipsychotics 62 hypoglycaemic episodes 62 thyroid dysfunction 62 recurrent VTE 62 thrombotic events 62 serum creatinine levels 62 prediabetes 62 elevated homocysteine 62 astrocytomas 62 thyrotropin 62 lichen planus 62 hepatic fibrosis 62 postmenopausal hormone 62 poor metabolizers 62 urinary oxalate 62 QTc prolongation 62 hypertriglyceridemia 62 impaired insulin secretion 62 eprotirome 62 Exacerbations 62 triglyceride concentrations 62 modifiable lifestyle 62 thromboembolic events 62 elevated uric acid 62 nondiabetics 62 protein excretion 62 lipid concentrations 62 coronary calcification 62 gastrointestinal GI bleeding 62 serum lipid 62 urinary calcium 62 macrovascular complications 62 nephropathy 62 untreated celiac disease 62 sulphonylurea 62 statin simvastatin 62 carotid plaques 62 subgroup analyzes 62 variceal bleeding 62 clomipramine 62 angiotensin II receptor blockers 62 C Reactive Protein 62 nondiabetic patients 62 aminotransferase levels 62 nonalcoholic fatty liver 62 rs# [004] 62 tricyclic antidepressants 62 microvascular complications 62 Avandia Actos 62 postoperative AF 62 Fasting glucose 62 Combination therapy 62 neurocognitive impairment 62 relapsed MM 62 flecainide 62 LV dysfunction 62 Nonalcoholic Fatty Liver Disease 62 non alcoholic steatohepatitis 62 lowering blood glucose 62 oral antidiabetic medication 62 comorbid disorders 62 NPH insulin 62 metabolic dysfunction 62 colorectal liver metastases 62 infliximab Remicade 62 AUDs 62 liver steatosis 62 potassium sparing diuretics 62 tiagabine 62 oral antidiabetic agents 62 adrenocortical cancer 62 Trandolapril 62 gefitinib Iressa 62 fluoxetine Prozac 62 arterial calcification 62 APTIVUS r 62 predisposing factors 62 Helicobacter pylori infection 62 vildagliptin 62 LHRH antagonists 62 preserved ejection fraction 62 Suicidal ideation 62 glycated hemoglobin 62 hydroxyvitamin D levels 62 gastric cancers 62 TT genotype 61 alcoholic fatty liver 61 overactive bladder symptoms 61 severe hypoglycemia 61 Impaired glucose tolerance 61 SLC#A# [002] 61 primary biliary cirrhosis 61 homozygous familial hypercholesterolemia 61 biphosphonates 61 histological subtype 61 torsades de pointes 61 bronchopulmonary dysplasia BPD 61 folate deficiency 61 lactic acidosis 61 reflux symptoms 61 lupus scleroderma 61 Primary IGFD 61 S. aureus isolates 61 CIN2 + 61 serum urate levels 61 ursodeoxycholic acid 61 hereditary hemochromatosis 61 hypophosphatemia 61 GnRH agonists 61 hyperphenylalaninemia HPA due 61 DMARDS 61 homocysteine concentrations 61 adenomatous polyps 61 comorbid depression 61 B7 H3 61 left ventricular dysfunction 61 cardiometabolic disorders 61 metabolic syndrome MetS 61 modifiable risk 61 gastro esophageal reflux 61 left ventricular hypertrophy 61 bezafibrate 61 rs# [001] 61 IGFBP 61 imatinib Gleevec 61 esophagogastric 61 cardiovascular disease hypertension 61 VLDL cholesterol 61 Cardiotoxicity 61 Haptoglobin 61 fasting triglyceride levels 61 aripiprazole Abilify 61 antiandrogens 61 Chronic pancreatitis 61 polyarticular 61 monogenic 61 ALT flares 61 acute humoral rejection 61 serum potassium 61 oral antidiabetic drugs 61 reflux disease 61 SSc 61 pulmonary exacerbations 61 hemoglobin A1c levels 61 CYP #A# 61 autoimmune thyroid 61 recurrent UTI 61 HLA DR 61 Candida infections 61 atherothrombosis 61 quetiapine Seroquel 61 serum PTH 61 recurrent miscarriage 61 CP CPPS 61 aldosterone antagonist 61 thiopurine 61 mixed dyslipidemia 61 non cirrhotic portal 61 bronchial hyperresponsiveness 61 etiologic factors 61 fasting glucose 61 Pioglitazone 61 systemic corticosteroid 61 anticoagulant warfarin 61 synthetic progestin 61 neurocognitive deficits 61 Hypertriglyceridemia 61 therapeutic regimens 61 oesophageal adenocarcinoma 61 TCF#L# 61 Non inferiority 61 metabolic acidosis 61 cytopenias 61 Warfarin Coumadin 61 thyrotropin levels 61 Telmisartan 61 amisulpride 61 recurrent DVT 61 familial pancreatic cancer 61 lupus anticoagulant 61 RAS blockers 61 essential thrombocythemia 61 proteinuria 61 CLA supplementation 61 Topiramate 61 non aspirin NSAIDs 61 tumor histology 61 lipid lowering drugs 61 gastric adenocarcinoma 61 antihypertensive medication 61 cystic fibrosis chronic pancreatitis 61 INCB# [003] 61 antiplatelet therapies 61 organochlorine compounds 61 impaired fasting glucose 61 vWD 61 serum retinol 61 HER2 expression 61 chronic thromboembolic pulmonary 61 euthymic patients 61 underlying pathophysiology 61 atopic disease 61 noncardiovascular 61 IgA deficiency 61 leukemia AML 61 chromium picolinate supplementation 61 QT prolongation 61 Observational studies 61 serotonin reuptake inhibitors 61 Impaired Glucose Tolerance 61 renal insufficiency 61 pramlintide 61 unresectable tumors 61 inflammatory rheumatic 61 clinically meaningful reductions 61 LANTUS ® 61 neuropsychiatric disorders 61 anticonvulsants 61 Hypoglycemia 61 pharmacological approaches 61 hepatic enzymes 61 BENICAR HCT 61 H pylori 61 improves glycemic 61 MYH9 gene 61 PsA 61 severe hypoglycaemia 61 GSTP1 61 alanine aminotransferase 61 glomerular filtration rate 61 Triglyceride 61 SHPT 61 trastuzumab Herceptin ® 61 trans palmitoleic acid 61 HDL LDL 61 serum lipids 61 gastro esophageal reflux disease 61 dermatomyositis 61 Lp PLA 2 61 Proteinuria 61 #q# deletion 61 tricyclic antidepressant 61 Mg Uk 61 Teriflunomide 61 nonvertebral fractures 61 pioglitazone HCl 61 VADT 61 chronic periodontitis 61 central adiposity 61 hepatotoxic 61 insulin sensitizers 61 intracranial hemorrhage ICH 61 hepatic lesions 61 intravesical therapy 61 atypical antipsychotic medications 61 Candida infection 61 renal scarring 61 insulin resistance 61 NIASPAN 61 vascular dysfunction 61 stone formers 61 obese postmenopausal 61 neuropathologic 61 silent myocardial ischemia 61 follicular adenoma 61 colorectal carcinogenesis 61 nephrolithiasis 61 plasma triglycerides 61 glycemia 61 Clusterin 61 CYP#D# 61 antiangiogenic therapy 61 efalizumab 61 triglyceride concentration 61 cardioprotective effects 61 serum calcium levels 61 fasting plasma glucose 61 SHBG levels 60 polycystic ovary syndrome PCOS 60 anti androgens 60 proctitis 60 sCJD 60 HER2 overexpression 60 acting insulin analogues 60 endometriosis ovarian cysts 60 hyperglycemia 60 hyperparathyroidism 60 AAT deficiency 60 Sjögren syndrome 60 morphometric vertebral fractures 60 Selective Serotonin Reuptake Inhibitor 60 PPAR γ 60 total cholesterol triglycerides 60 aspirin clopidogrel 60 hydroxychloroquine 60 interleukin IL -# 60 flutamide 60 nonfasting triglyceride levels 60 receptor subtypes 60 antidiabetic drug 60 cirrhosis liver failure 60 postmenopausal breast cancer 60 H2 receptor antagonists 60 lipid lowering medications 60 Hyperlipidemia 60 thalidomide Thalomid 60 lomitapide 60 severe renal impairment 60 genetic syndromes 60 atrophic gastritis 60 testicular tumors 60 autoantibody levels 60 cholesterol LDL C 60 hepatorenal syndrome 60 intracerebral haemorrhage 60 atopic eczema 60 obstructive coronary artery 60 molecular abnormalities 60 glomerular filtration 60 serum triglyceride levels 60 allograft rejection 60 antidepressants SSRIs 60 lipid lowering therapy 60 arterial thrombosis 60 pegylated interferons 60 serum uric acid 60 GBA mutations 60 hypogonadotropic hypogonadism 60 Comorbid 60 Naive Patients 60 vertebral fracture 60 prognostic markers 60 coronary stenosis 60 dyslipidemia 60 statins cholesterol lowering 60 cardioembolic stroke 60 urothelial carcinoma 60 peritumoral brain edema 60 HNSCC 60 memantine Namenda 60 Alagebrium 60 vitamin B# deficiency 60 testosterone supplementation 60 prenatal exposures 60 post thrombotic syndrome 60 chromosomal rearrangement 60 lobular carcinoma 60 thrombotic complications 60 hsCRP levels 60 osteosarcomas 60 baseline serum creatinine 60 intranasal corticosteroids 60 trans retinoic acid 60 folate intake 60 atherothrombotic disease 60 albumin excretion 60 APOE genotype 60 EoE 60 gastro oesophageal reflux 60 PAOD 60 cardiac biomarkers 60 AGHD 60 Dental caries 60 citalopram Celexa 60 DVT PE 60 nicardipine 60 Spironolactone 60 hyperlipidaemia 60 Angiotensin receptor blockers 60 visilizumab 60 fetuin 60 density lipoprotein cholesterol HDL 60 univariate analyzes 60 insulin resistance precursor 60 Statin therapy 60 antigen PSA 60 angiotensin converting enzyme inhibitors 60 paraneoplastic 60 impaired glucose tolerance 60 SERMs 60 aromatase inhibitors AIs 60 hyperlipidemia 60 Subgroup analyzes 60 TGFBR1 * 6A 60 extrapyramidal symptoms EPS 60 riociguat 60 acute myocardial infarction MI 60 Fanconi syndrome 60 Microalbuminuria 60 QT interval prolongation 60 autonomic dysfunction 60 RISPERDAL ® 60 glulisine 60 skeletal metastases 60 V Leiden 60 alpha interferons 60 glucose abnormalities 60 residual confounding 60 ovarian pancreatic 60 Apolipoprotein E 60 beta carotene supplementation 60 TZDs 60 platelet inhibitor 60 5alpha reductase 60 haptoglobin 60 postprandial hyperglycemia 60 herpes zoster shingles 60 insulin sensitizing 60 hematological parameters 60 acetabular dysplasia 60 tumor hypoxia 60 PCa 60 Primary Hypercholesterolemia 60 serum IGF 60 macrolide antibiotic 60 monoinfected patients 60 Vidaza azacitidine 60 indinavir 60 caspofungin 60 cTnT 60 prolactin levels 60 metabolic syndrome 60 thiazide diuretic 60 inversely associated 60 CANCIDAS 60 hyperbilirubinemia 60 Elevated triglycerides 60 HLA DRB1 60 unmeasured factors 60 Lipoic acid 60 Homocysteine 60 cardio metabolic 60 oxysterols 60 primidone 60 gene polymorphism 60 Alzheimer disease vascular dementia 60 microvascular disease 60 prognostic indicators 60 steatohepatitis 60 triacylglycerol concentrations 60 neovascular diseases 60 rs# [002] 60 Pseudomonas aeruginosa infections 60 hematologic toxicity 60 5 HTTLPR 60 psychiatric comorbidities 60 carcinoid tumors 60 Squamous 60 density lipoprotein cholesterol 60 autoimmune thyroiditis 60 CHD mortality 60 RBP4 60 invasive candidiasis 60 purpura ITP 60 CYP#A# inhibitors 60 anemias 60 hyperlipemia 60 advanced adenoma 60 osteopenic 60 SRBD 60 hamartomas 60 cardiac toxicity 60 POAG 60 ALT elevations 60 KIF6 gene 60 confidence interval #.#-#.# 60 candesartan cilexetil 60 Ascherio 60 metformin monotherapy 60 Heavy snorers 60 hyperammonemia 60 acute GVHD 60 IDDM 60 liver dysfunction 60 pyelonephritis 60 Angiotensin converting enzyme 60 MetS 60 Alanine 60 protease inhibitor PI 60 Chlamydia pneumoniae 60 estrone 60 platelet reactivity 60 dopamine D2 60 plasma homocysteine 60 anti epileptics 60 Chlamydia infection 60 haemorrhagic stroke 60 recurrent acute pancreatitis 60 slow metabolizers 60 juvenile idiopathic arthritis 60 depressive symptomatology 60 H. pylori eradication 60 pleiotropic effects 60 hyperplasia BPH 60 idraparinux 60 gemifloxacin 60 hawthorn extract 60 Quetiapine 60 fasting insulin 60 alpha1 antitrypsin AAT deficiency 60 neurologic complications 60 Wernicke encephalopathy 60 HOMA IR 60 serum vitamin D 60 somatostatin analog 60 #HT#A partial agonist 60 chemotherapeutic regimens 60 biochemical abnormalities 60 elevated creatinine 60 L lysine 60 Valproate 60 EXJADE 60 GH deficiency 60 hyperinsulinism 60 NNT = 60 cardio metabolic diseases 60 ocular toxicity 60 predisposing factor 60 diuretic hydrochlorothiazide 60 density lipoprotein HDL cholesterol 60 SCr 60 microbleeds 60 hepatic steatosis 60 aspartate aminotransferase AST 60 chromosome #p#.# 60 aspartate aminotransferase 60 ALB # 60 delta gamma agonist 60 pioglitazone Actos 60 selenium supplementation 59 Magnesium deficiency 59 fluoxetine paroxetine 59 dietary interventions 59 symptomatic VTE 59 hyperprolactinemia 59 mycophenolate mofetil MMF 59 seminomas 59 plasminogen activators 59 antiepileptics 59 diastolic hypertension 59 isoprostane 59 LDL cholesterol concentrations 59 tumor subtypes 59 PREZISTA r 59 URTI 59 cardiac dysfunction 59 Trichomonas vaginalis 59 overt hypothyroidism 59 liver metastasis 59 abacavir Ziagen 59 pancreatic prostate 59 Selective serotonin reuptake inhibitors 59 Renal dysfunction 59 Toxicities 59 thyroxine 59 prognostic indicator 59 nonpharmacologic 59 Hypercholesterolemia 59 genetic determinants 59 nephrotoxicity 59 tibolone 59 susceptibility gene 59 Comorbidities 59 colonic polyps 59 antihypertensive agents 59 postprandial glycemia 59 Severe Primary IGFD 59 androgen depletion 59 hepatic encephalopathy 59 pheochromocytoma 59 Pulmonary hypertension 59 plasma folate 59 typical antipsychotics 59 serum selenium 59 triglyceride TG 59 breast cancer metastasis 59 Lipoprotein 59 KRAS status 59 fasting plasma 59 urinary symptoms 59 GSTT1 59 antiphospholipid syndrome 59 thiazolidinediones 59 Zollinger Ellison syndrome 59 late onset hypogonadism 59 genetic loci 59 CagA 59 demonstrated antitumor activity 59 nanomolar 59 serum PSA 59 non affective psychosis 59 plasma renin activity 59 invasive ductal 59 serum cotinine levels 59 Relapsing remitting MS 59 lipid profiles 59 #mg/dL [001] 59 sildenafil Viagra 59 Hp2 2 59 aldosterone antagonists 59 Endothelial dysfunction 59 insulin degludec 59 diagnostic biomarker 59 developmental neurotoxicity 59 Vitamin D insufficiency 59 gastrointestinal toxicity 59 atherothrombotic 59 VAPRISOL 59 hyperoxaluria 59 sodium glucose cotransporter 59 colorectal cancer CRC 59 HBeAg positive 59 polycythemia vera PV 59 probiotic supplementation 59 laboratory abnormalities 59 Akathisia 59 RoACTEMRA 59 LHRH analogues 59 standard chemotherapy regimens 59 perilipin 59 Hypotension 59 coinfection 59 umol L 59 neuroleptic 59 chromium supplementation 59 esophagitis 59 Navelbine ® 59 nucleoside analogues 59 creatine supplementation 59 sotalol 59 chronic eosinophilic leukemia 59 gastric carcinogenesis 59 Muraglitazar 59 Febrile neutropenia 59 erythropoietic 59 familial amyloidotic polyneuropathy FAP 59 prognostic variables 59 eplerenone 59 acute rheumatic fever 59 supine hypertension 59 gastrointestinal adverse reactions 59 dietary modification 59 progressive dyspnea 59 estrogen deficiency 59 corticosteroid therapy 59 antithrombotic agents 59 TNF blocker therapy 59 hepatocellular 59 comorbid conditions 59 newer antipsychotic medications 59 Polycythemia vera 59 atherogenesis 59 atypical hemolytic uremic syndrome 59 somatic symptoms 59 lymphoproliferative disorders 59 atrial arrhythmias 59 anticholinergic effects 59 TNFalpha 59 transaminases 59 CYP#C# [001] 59 angiotensin receptor blockers 59 urate levels 59 biologic pathways 59 LDL HDL 59 steroid dexamethasone 59 cholesterols 59 pathophysiological mechanisms 59 intestinal polyps 59 Dapagliflozin 59 mealtime insulin 59 malignant lymphoma 59 labetalol 59 LDL cholesterol lowering 59 dopaminergic therapy 59 CYP#D# gene 59 prednisone prednisolone 59 fluconazole resistant 59 ruboxistaurin 59 Pischon 59 bacterial prostatitis 59 serous ovarian cancer 59 Leydig cell 59 COPD exacerbations 59 basal cell carcinoma BCC 59 plasma kallikrein 59 delayed gastric emptying 59 potassium excretion 59 acne vulgaris 59 allogeneic HSCT 59 neurodevelopmental outcome 59 APOE e4 59 triiodothyronine 59 SGAs 59 renal artery stenosis 59 ovarian lung 59 liver transaminases 59 COX inhibitors 59 diabetic gastroparesis 59 proliferator activated receptor